OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,214 | -66.1% | 20,132 | -44.3% | 0.00% | – |
| Q2 2023 | $186,508 | +92.1% | 36,145 | +96.2% | 0.00% | – |
| Q1 2023 | $97,094 | +363.7% | 18,424 | +147.3% | 0.00% | – |
| Q4 2022 | $20,937 | -36.6% | 7,451 | -7.3% | 0.00% | – |
| Q3 2022 | $33,000 | -96.0% | 8,034 | -96.1% | 0.00% | -100.0% |
| Q2 2022 | $826,000 | +717.8% | 205,551 | +910.7% | 0.00% | – |
| Q1 2022 | $101,000 | -56.3% | 20,337 | -38.6% | 0.00% | – |
| Q4 2021 | $231,000 | -49.5% | 33,096 | -27.5% | 0.00% | – |
| Q3 2021 | $457,000 | +53.4% | 45,657 | +117.0% | 0.00% | – |
| Q2 2021 | $298,000 | +27.9% | 21,044 | +48.5% | 0.00% | – |
| Q1 2021 | $233,000 | -47.6% | 14,173 | -34.0% | 0.00% | – |
| Q4 2020 | $445,000 | +163.3% | 21,483 | -3.2% | 0.00% | – |
| Q3 2020 | $169,000 | +85.7% | 22,186 | +104.2% | 0.00% | – |
| Q2 2020 | $91,000 | +13.8% | 10,867 | -32.5% | 0.00% | – |
| Q1 2020 | $80,000 | +77.8% | 16,095 | +41.5% | 0.00% | – |
| Q4 2019 | $45,000 | -27.4% | 11,376 | -44.2% | 0.00% | – |
| Q3 2019 | $62,000 | -48.3% | 20,401 | -25.1% | 0.00% | – |
| Q2 2019 | $120,000 | -10.4% | 27,225 | -19.5% | 0.00% | – |
| Q1 2019 | $134,000 | -24.3% | 33,820 | -23.4% | 0.00% | – |
| Q4 2018 | $177,000 | +4.7% | 44,166 | +80.1% | 0.00% | – |
| Q3 2018 | $169,000 | +29.0% | 24,528 | +26.4% | 0.00% | – |
| Q2 2018 | $131,000 | 0.0% | 19,400 | -3.2% | 0.00% | – |
| Q1 2018 | $131,000 | +37.9% | 20,048 | -6.3% | 0.00% | – |
| Q4 2017 | $95,000 | +26.7% | 21,394 | +77.3% | 0.00% | – |
| Q3 2017 | $75,000 | -70.9% | 12,069 | -56.6% | 0.00% | – |
| Q2 2017 | $258,000 | +7.9% | 27,796 | +8.2% | 0.00% | – |
| Q1 2017 | $239,000 | +2887.5% | 25,686 | +1485.6% | 0.00% | – |
| Q2 2016 | $8,000 | -92.2% | 1,620 | -84.6% | 0.00% | – |
| Q1 2016 | $102,000 | +131.8% | 10,522 | +124.4% | 0.00% | – |
| Q4 2015 | $44,000 | – | 4,689 | +156200.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 3 | -98.2% | 0.00% | – |
| Q2 2015 | $4,000 | -69.2% | 169 | -46.3% | 0.00% | – |
| Q1 2015 | $13,000 | -98.1% | 315 | -98.9% | 0.00% | -100.0% |
| Q4 2014 | $698,000 | +23166.7% | 29,673 | +14662.7% | 0.00% | – |
| Q3 2014 | $3,000 | – | 201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |